128 related articles for article (PubMed ID: 37401857)
1. Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.
Narasimman M; Hernaez R; Cerda V; Lee M; Sood A; Yekkaluri S; Khan A; Quirk L; Liu Y; Kramer JR; Craddock Lee S; Murphy CC; Tiro JA; Singal AG
Hepatology; 2024 Jan; 79(1):107-117. PubMed ID: 37401857
[TBL] [Abstract][Full Text] [Related]
2. Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
Narasimman M; Hernaez R; Cerda V; Lee M; Yekkaluri S; Khan A; Sood A; Gurley T; Quirk L; Liu Y; Kramer JR; Lee SC; Tiro JA; Murphy CC; Singal AG
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):760-767.e1. PubMed ID: 37544418
[TBL] [Abstract][Full Text] [Related]
3. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
4. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
Parikh ND; Singal AG; Hutton DW; Tapper EB
Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
[TBL] [Abstract][Full Text] [Related]
6. An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy.
Beal EW; Albert S; McNally M; Shirley LA; Hanje J; Michaels AJ; Black SM; Bloomston M; Schmidt CR
J Surg Oncol; 2014 Dec; 110(8):967-9. PubMed ID: 25155168
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
8. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
Singal AG; Reddy S; Radadiya Aka Patel H; Villarreal D; Khan A; Liu Y; Cerda V; Rich NE; Murphy CC; Tiro JA; Kramer JR; Hernaez R
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2818-2825.e1. PubMed ID: 34902568
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
[TBL] [Abstract][Full Text] [Related]
10. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
Curran C; Priest M; Datta S; Forrest EH; Stanley AJ; Barclay ST
Dig Dis Sci; 2023 Mar; 68(3):770-777. PubMed ID: 36376575
[TBL] [Abstract][Full Text] [Related]
12. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
13. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
[TBL] [Abstract][Full Text] [Related]
14. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.
McGowan CE; Edwards TP; Luong MU; Hayashi PH
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):799-804. PubMed ID: 25117773
[TBL] [Abstract][Full Text] [Related]
16. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures.
Fan R; Chen L; Zhao S; Yang H; Li Z; Qian Y; Ma H; Liu X; Wang C; Liang X; Bai J; Xie J; Fan X; Xie Q; Hao X; Wang C; Yang S; Gao Y; Bai H; Dou X; Liu J; Wu L; Jiang G; Xia Q; Zheng D; Rao H; Xia J; Shang J; Gao P; Xie D; Yu Y; Yang Y; Gao H; Liu Y; Sun A; Jiang Y; Yu Y; Niu J; Sun J; Wang H; Hou J
J Hepatol; 2023 Oct; 79(4):933-944. PubMed ID: 37302583
[TBL] [Abstract][Full Text] [Related]
17. Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study.
Im S; Jang ES; Lee JH; Lee CS; Kim BH; Chung JW; Kim JW; Jeong SH
Cancer Res Treat; 2019 Oct; 51(4):1357-1369. PubMed ID: 30744319
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Roudot-Thoraval F; Audureau E;
Gastroenterology; 2018 Nov; 155(5):1436-1450.e6. PubMed ID: 30031138
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Reddy KR; McLerran D; Marsh T; Parikh N; Roberts LR; Schwartz M; Nguyen MH; Befeler A; Page-Lester S; Tang R; Srivastava S; Rinaudo JA; Feng Z; Marrero JA
Gastroenterology; 2023 Oct; 165(4):1053-1063.e6. PubMed ID: 37429366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]